These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2060078)

  • 21. A review of neuromuscular blockade in the critically ill patient.
    Michaud D; Abbas M; Gélinas C
    Dynamics; 2002; 13(3):11. PubMed ID: 12640839
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuromuscular blocking drugs.
    Norman J
    Br J Anaesth; 1979 Jun; 51(6):471-3. PubMed ID: 223613
    [No Abstract]   [Full Text] [Related]  

  • 23. A method to improve clinical assessment of neuromuscular recovery.
    Tammisto T; Wirtavuori K
    Anesth Analg; 1995 Dec; 81(6):1319. PubMed ID: 7486140
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuromuscular blocking drugs and their antagonists in patients with organ disease.
    Craig RG; Hunter JM
    Anaesthesia; 2009 Mar; 64 Suppl 1():55-65. PubMed ID: 19222432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuromuscular blocking drugs in anaesthesia.
    Donati F; Bevan JC; Bevan DR
    Can Anaesth Soc J; 1984 May; 31(3 Pt 1):324-36. PubMed ID: 6372957
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuromuscular pharmacology. A clinical update and commentary.
    Lee C; Katz RL
    Br J Anaesth; 1980 Feb; 52(2):173-88. PubMed ID: 6244842
    [No Abstract]   [Full Text] [Related]  

  • 27. A simple system of quantitative monitoring of neuromuscular block.
    Soroker D; Lurie S; Ezri T
    Acta Anaesthesiol Scand; 1993 Apr; 37(3):319. PubMed ID: 8517110
    [No Abstract]   [Full Text] [Related]  

  • 28. Muscle relaxants and reversal agents.
    Van Sickel AD; Spadaccia K
    Crit Care Nurs Clin North Am; 1991 Mar; 3(1):151-8. PubMed ID: 2043325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Manual evaluation of residual curarization using double burst stimulation: a comparison with train-of-four.
    Drenck NE; Ueda N; Olsen NV; Engbaek J; Jensen E; Skovgaard LT; Viby-Mogensen J
    Anesthesiology; 1989 Apr; 70(4):578-81. PubMed ID: 2929994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of measurement techniques: agreement is not correlation.
    Myles PS
    Anaesth Intensive Care; 1995 Aug; 23(4):522-3. PubMed ID: 7485963
    [No Abstract]   [Full Text] [Related]  

  • 31. Postoperative residual neuromuscular block: a survey of management.
    Baillard C; Clec'h C; Catineau J; Salhi F; Gehan G; Cupa M; Samama CM
    Br J Anaesth; 2005 Nov; 95(5):622-6. PubMed ID: 16183681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basic principles of neuromuscular transmission.
    Martyn JA; Fagerlund MJ; Eriksson LI
    Anaesthesia; 2009 Mar; 64 Suppl 1():1-9. PubMed ID: 19222426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuromuscular blockade.
    Lancet; 1990 Feb; 335(8686):382-4. PubMed ID: 1968120
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of neuromuscular-blocking agents in children.
    Tobias JD
    Pediatr Ann; 1997 Aug; 26(8):482-9. PubMed ID: 9263302
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacology of the neuromuscular junction.
    Gardier RW
    Acta Anaesthesiol Belg; 1974; 25(3):413-24. PubMed ID: 4466322
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular mechanisms of neuromuscular blocking agents: is the increased understanding of importance to the practising anaesthetist?
    Aglan MY; Pollard BJ
    Pharmacol Ther; 1995; 68(3):365-83. PubMed ID: 8788563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents.
    Viby-Mogensen J; Engbaek J; Eriksson LI; Gramstad L; Jensen E; Jensen FS; Koscielniak-Nielsen Z; Skovgaard LT; Ostergaard D
    Acta Anaesthesiol Scand; 1996 Jan; 40(1):59-74. PubMed ID: 8904261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The undesirable effects of neuromuscular blocking drugs.
    Claudius C; Garvey LH; Viby-Mogensen J
    Anaesthesia; 2009 Mar; 64 Suppl 1():10-21. PubMed ID: 19222427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neuromuscular transmission monitor. A clinical assessment and comparison with a force transducer.
    Windsor JP; Sebel PS; Flynn PJ
    Anaesthesia; 1985 Feb; 40(2):146-51. PubMed ID: 2983581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge.
    Butterly A; Bittner EA; George E; Sandberg WS; Eikermann M; Schmidt U
    Br J Anaesth; 2010 Sep; 105(3):304-9. PubMed ID: 20576632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.